RadiaDyn: AngioDynamics (ANGO) Announces OARtrac Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation Therapy

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that the United States Food and Drug Administration (FDA) granted an expanded 510(k) clearance for the OARtrac Radiation Dose Monitoring System.